Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:developedBy |
Altropane
Cethrin |
| gptkbp:focusesOn |
central nervous system disorders
|
| gptkbp:formerName |
Boston Life Sciences
|
| gptkbp:headquartersLocation |
gptkb:Hopkinton,_Massachusetts,_United_States
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
ALSE
|
| gptkbp:bfsParent |
gptkb:David_Elmaleh
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Alseres Pharmaceuticals
|